TTRX
Turn Therapeutics Inc. Common Stock
NASDAQ: TTRX · HEALTHCARE · BIOTECHNOLOGY
$3.69
+3.81% today
Updated 2026-04-30
Market cap
$107.24M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.12
Dividend yield
—
52W range
$3 – $10
Volume
0.0M
Turn Therapeutics Inc. Common Stock (TTRX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | $2.01M | $2.05M |
| Cash & equivalents | $1.18M | $872599.00 |
| Current assets | $1.20M | $1.10M |
| Total liabilities | $1.93M | $2.23M |
| Current liabilities | $489779.00 | $707932.00 |
| Long-term debt | — | — |
| Shareholder equity | $85768.00 | $-177432.00 |
| Retained earnings | $-17.43M | $-19.20M |
| Accounts receivable | — | — |
| Inventory | — | — |
| Goodwill | — | — |